A new lethal brittle bone syndrome with increased amount of type V collagen in a patient.
A new lethal brittle bone disease is described in three patients with slender long bones, thin ribs, hypomineralized calvaria, and normal facial appearance. In spite of several limb fractures this syndrome can be differentiated from the lethal forms of osteogenesis imperfecta and is better related to the thin-bone group of lethal dysplasias. Biochemical investigation of collagen from one of the patients by the use of gel electrophoresis and high-pressure liquid chromatography analyses failed to demonstrate any evident defect in the structure of type I collagen chains. Nevertheless collagen extractability from the dermis was altered owing to an increase in the proportion of acid-soluble material. Tritium-proline labeling of cultured fibroblasts confirmed the reduction in total collagen synthesis. This was attributed to a lower type I and type III amount whereas type V collagen level was markedly increased in the cell layer. RNA analysis of the three collagen types with the appropriate cDNA probes confirmed the protein data. Electron microscopic examination of bone and skin showed morphologically abnormal fibroblasts and osteoblasts with an abundant distended rough endoplasmic reticulum and an altered plasma membrane. Unexpected thin fibrils with a banding pattern and surrounding the type I fibrils were observed. They might represent type V collagen. We suggest that, in this patient, the moderate decrease in type I collagen amount is insufficient to account for the radiological findings and that type V collagen overproduction could play a role in the bone brittleness by interfering with the process of mineralization.
Bonaventure
J
J
Unité de Recherches de Génétique Médicale, Hôpital des Enfants-Malades, Paris, France.
Zylberberg
L
L
Cohen-Solal
L
L
Allain
J C
JC
Lasselin
C
C
Maroteaux
P
P
D001848:Bone Diseases, Developmental / Q000209:etiology* / Q000378:metabolism; D001842:Bone and Bones / Q000032:analysis; D002853:Chromatography, Liquid; D003094:Collagen / Q000032:analysis* / Q000235:genetics / Q000302:isolation & purification / Q000648:ultrastructure; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005317:Fetal Growth Retardation; D005347:Fibroblasts / Q000378:metabolism; D005598:Fractures, Spontaneous; D005804:Genes, Lethal; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008854:Microscopy, Electron; D011247:Pregnancy; D012313:RNA / Q000032:analysis; D012867:Skin / Q000032:analysis; D013577:Syndrome
D012313:RNA; D003094:Collagen